Anlon Healthcare IPO GMP: Day 3 IPO Live Updates

The Anlon Healthcare IPO GMP is ₹91 as of 29th August 2025. It is a bookbuilding IPO of ₹121.03 crores. This is a new issue of 1.33 crore shares. The issue will be listed on BSE and NSE on its tentative listing date, 3rd September 2025. The face value of Anlon Healthcare shares stands at ₹10 per share, and the IPO price band is set at ₹86.00 to ₹91.00 per share. Retail investors can bid for a minimum of one lot of 164 shares worth ₹14,924. 

Anlon Healthcare IPO GMP Grey Market Premium

As of 29th August 2025, the Anlon Healthcare IPO GMP stands at ₹2 per share. Thus, the estimated listing price would be ₹93. This indicates that the estimated listing gain in this IPO could be 2.20%. However, GMP details are subject to change based on market conditions and fluctuations. Explore the table for the Anlon Healthcare IPO GMP updates.

Anlon Healthcare IPO Details

Explanation

Anlon Healthcare IPO: Anlon Healthcare Limited has declared that the issue price band is set between ₹86.00 and ₹91.00  per share. With this IPO, the company allows retail investors to bid for at least one lot of 164 shares worth ₹14,924. The face value of Anlon Healthcare Limited shares is ₹10 per share. The shares of Anlon Healthcare Limited will be listed on BSE and NSE on its tentative listing day, 3rd September 2025. Scroll down to check GMP updates and Anlon Healthcare IPO reviews. 

Objectives of the Anlon Healthcare IPO

The primary aim of the Anlon Healthcare IPO is to raise ₹121.03 crores. On the other hand, Anlon Healthcare has decided to utilise these funds in different ways. Explore some of the secondary objectives for the Anlon Healthcare IPO.

• To meet the general corporate purpose.
• To fund the working capital requirement. 
• To fund capital requirements for the expansion.
• To prepay certain borrowings of the company.

Anlon Healthcare IPO Registrar

Kfin Technologies Limited is the registrar of the Anlon Healthcare IPO, responsible for managing the IPO allotment process and initiating refunds. For any queries regarding the Anlon Healthcare allotment and refund, you can contact Kfin Technologies Private Limited at

reachus@kfintech.com, 04067162222, 04079611000. 

 Anlon Healthcare IPO Review  

The Anlon Healthcare IPO has gained neutral ratings from industry experts, brokers, and institutional investors. Anlon Healthcare Limited’s revenue increased by 81% from ₹66.69 crores in March 2024 to ₹120.46 crores in March 2025. Moreover, the company’s PAT rose by 112% from ₹9.66 crores to ₹20.52 crores. Investors can analyse other relevant factors and make a decision accordingly.

Most analysts recommend applying for this IPO to diversify your investment portfolio in the stock market. However, we’re waiting for further ratings to gain a better understanding and will continue to post them to deliver real-time insights. Until then, you can explore the company’s technical analysis to know whether you should apply for the Anlon Healthcare IPO or not.

Anlon Healthcare Limited Technicals

The PE ratio of Anlon Healthcare Limited shares is 17.67, and its Earnings Per Share (EPS) stands at ₹5.15. Thus, the Anlon Healthcare IPO can potentially deliver gains on its tentative listing date, 3rd September 2025. 

Note: The data, as mentioned above, is taken from authentic sources and highlights pre-issue information. The PE ratio and EPS of Anlon Healthcare Limited are subject to change after the IPO. Refer to the table below for post-issue updates on these two metrics. 

Anlon Healthcare Limited IPO Peer Comparison

FAQs on Anlon Healthcare IPO

What is the Anlon Healthcare IPO GMP?

Ans. Currently, on 29th August 2025, the Anlon Healthcare IPO GMP (Grey Market Premium) stands at ₹2. This indicates that the estimated listing price could be ₹93 per share.

What is the issue price of the Anlon Healthcare IPO?

Ans. The Anlon Healthcare IPO price is set at ₹86.00 to 91.00 per share.  Retail investors can apply for a minimum of 1 lot consisting of 164 shares worth ₹14,925. Moreover, HNIs are required to bid for a minimum of 14 lots (2,296 shares) worth ₹2,08,936.

Who is the registrar of the Anlon Healthcare IPO?

Ans. Kfin Technologies Private Limited is the registrar of the Anlon Healthcare IPO, responsible for managing the IPO allotment process and initiating refunds. For any queries regarding the Anlon Healthcare allotment and refund, you can contact Kfin Technologies.

Private limited at reachus@kfintech.com, 04067162222, 04079611000. 

Disclaimer: The above information is compiled from authentic sources and is just for informational purposes. To have detailed information about the Anlon Healthcare IPO, download the Anlon Healthcare IPO RHP and Anlon Healthcare IPO DRHP. Conduct thorough research before investing in IPOs to minimise the risk of significant losses. You can also consult your financial advisor.

Recent Articles

Droom IPO Details: Everything You Should Know about

Upcoming IPO: Optivalue Tek Consulting, Goel Construction Co, Austere Systems

Best Stocks Under ₹100 in 2025 for Potential Returns

White Organic Retail Q1 Results FY26: Q1 PAT Fall 194.39% to -₹1.77 Crore; Revenue Up -% YoY

Prabhat Technologies Q1 Results FY26: Q1 PAT Fall 34.09% to -₹0.76 Crore; Revenue Up 93.95% YoY

Godha Cabcon and Insulation Q1 Results FY26: Q1 PAT Rises 53.47% to ₹0.69 Crore; Revenue Down 39.92% YoY